በካንሳስ ለየክሮን በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች
ለየክሮን በሽታ የሚደረጉ 11 ጥናቶች በካንሳስ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በካንሳስ ውስጥ ያሉ ከተሞች
Official study text (English)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Kansas Medical Center ( Site 5091), Kansas City
- Cotton O'Neil Digestive Health Center ( Site 5033), Topeka
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06430801A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Hutchinson Clinic, Hutchinson
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06581328A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Cotton-O'Neil Clinical Research Center, Topeka
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Kansas Gastroenterology, LLC, Wichita
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- University of Kansas Medical Center, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06233461Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- እና 7 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- University of Kansas Medical Center-Site Number: 8400110, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07184931A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Cotton O'Neil Digestive Health Center, Topeka
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Cotton O'Neil Digestive Health Center, Topeka
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- University of Kansas Medical Center, Kansas City
- Cotton ONeil Clinical Research Center, Topeka
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06045754A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400006, Kansas City
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ27 ማርች 2026 · NCT06958536ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።